Rawalpindi: BF Biosciences Limited has announced that its Annual General Meeting (AGM) will be held on Saturday, October 25, 2025, at 12:15 P.M. The meeting is set to take place at Blue Lagoon, Masood Akhtar Kiani Road, Rawalpindi, and will also be accessible via video-link. This gathering aims to address several crucial items of business for the company.
The meeting will commence with the confirmation of the minutes from the previous AGM held on October 28, 2024. Shareholders will then review and consider the audited financial statements for the fiscal year ending June 30, 2025. These statements will be accompanied by the Chairman’s Review, along with reports from the Directors and Auditors.
A significant agenda item is the appointment of auditors for the upcoming fiscal year ending June 30, 2026. Shareholders will also determine the remuneration for these auditors.
According to information available from the Pakistan Stock Exchange (PSX), a notable component of the AGM will be the consideration of related party transactions conducted during the financial year 2024-25. Shareholders will deliberate on authorizing the Board of Directors to approve all future related party transactions. This decision is set to be ratified through proposed special resolutions.
The AGM will also entertain any other business matters that arise with the permission of the chair. The company has ensured that a statement of material facts and relevant disclosures, as required by the Companies Act, 2017, are being distributed to shareholders along with the AGM notice.
For comprehensive details, the complete notice and financial statements for the year ending June 30, 2025, have been made available on the company’s official website, www.btbio.com. The notice was issued by the order of Abdur Rehman, the Company Secretary.